NORMAN J CLEMENT RPH., DDS, NORMAN L.CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., IN THE SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., WALTER F. WRENN III., MD., JULIE KILLINGWORTH, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NDJOU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
RICHARD LAWHERN PH.D.
The US Pain Foundation has provided a gateway for you as individual patients to tell Congress what you think about the draft CDC guidelines on prescription opioids. We need tens of thousands of patients and caregivers to “weigh-in” with their own words.
Please use the “Send Your Message” link at the bottom of the US Pain Foundation’s article. The following is my own input:
Updated Draft CDC Opioid Prescribing Guideline
I speak and write as a subject matter expert on public policy for the regulation of prescription opioid pain relievers and doctors who employ them in treating people in agony.
I have separately submitted a 5500-word paper to NCIPC/BSC that debunks this entire fatally flawed document.
This message is in reference to the Updated Draft Opioid Prescribing Guideline which the CDC National Center for Injury Prevention and Control (NCIPC) released on Friday, July 16.
THE GUIDELINE HAVE HARMED MANY PAIN PATIENTS
This Guideline is virtually identical to the 2016 version and focuses extensively on reducing and eliminating the legitimate use of opioids for pain management which has harmed many pain patients who have been abruptly forced off medication they use appropriately and rely on to function.
Yet the Guideline remains silent on what patients living with high-impact, relentless, severe pain should do for pain management beyond recommending non-opioid therapies, many of which have significant access barriers.
Of central concern is that the entire conceptual framework of this fatally flawed document is centered on restrictions of Morphine Milligram Equivalent Dose — a concept that is long known to be actively harmful junk science.
Despite a huge body of highly critical feedback from the medical and scientific community, NCIPC continues in its stubborn and unfounded attempts to suppress prescription opioids in pain management practice.
CONGRESS MUST CLEAN UP THIS MESS
It is time for Congress to intervene and demand repudiation and withdrawal of the guidelines — without replacement.
Please fill out the form on this page and include a personal statement on why you need better #PainCareNOW.
For the U.S. Pain Foundation’s Virtual Advocacy Day 2021, we’re asking that you reach out to your representatives and request that the Pain Management Task Force (PMTF) Report, which strongly advocates the importance of multidisciplinary care, be disseminated to the nation’s frontline providers across the country.
Now more than ever—especially in light of the COVID-19 pandemic—people with pain are isolated and unable to receive the care they desperately need. Specifically, we are asking Congress to urge HHS to disseminate the PMTF report to:
- Teach doctors about the full range of multidisciplinary treatments in the categories of medication, restorative therapies, interventional procedures, behavioral health, and complementary and integrative therapies
2. Improve coverage for a full range of treatments
FOR NOW, YOU ARE WITHIN